Nanomedicine-Based Strategies for Diabetes: Diagnostics, Monitoring, and Treatment

Overview

Journal Trends Endocrinol Metab

Specialty Endocrinology

Date 2020 May 13

PMID 32396845

Citations 17

Authors

Luke R Lemmerman

Devleena Das

Natalia Higuita-Castro

Raghavendra G Mirmira

Daniel Gallego-Perez

Affiliations

Soon will be listed here.

Abstract

Traditional methods for diabetes management require constant and tedious glucose monitoring (GM) and insulin injections, impacting quality of life. The global diabetic population is expected to increase to 439 million, with approximately US$490 billion in healthcare expenditures by 2030, imposing a significant burden on healthcare systems worldwide. Recent advances in nanotechnology have emerged as promising alternative strategies for the management of diabetes. For example, implantable nanosensors are being developed for continuous GM, new nanoparticle (NP)-based imaging approaches that quantify subtle changes in β cell mass can facilitate early diagnosis, and nanotechnology-based insulin delivery methods are being explored as novel therapies. Here, we provide a holistic summary of this rapidly advancing field compiling all aspects pertaining to the management of diabetes.

Citing Articles

The Application of Nanomaterials in the Treatment of Pancreatic-Related Diseases.

Ma J, Li X, Wang C Int J Mol Sci. 2024; 25(23).

PMID: 39684868 PMC: 11641907. DOI: 10.3390/ijms252313158.

"Therapeutic advancements in nanomedicine: The multifaceted roles of silver nanoparticles".

Karunakar K, Cheriyan B, R K, M G, B A Biotechnol Notes. 2024; 5:64-79.

PMID: 39416696 PMC: 11446369. DOI: 10.1016/j.biotno.2024.05.002.

Metallic nanoentities: Bio-engineered silver, gold, and silver/gold bimetallic nanoparticles for biomedical applications.

Mujahid S, Ambreen N, Yaseen M, Ihtesham M, Khan K, Nasimullah Qureshi M Heliyon. 2024; 10(18):e37481.

PMID: 39328505 PMC: 11425117. DOI: 10.1016/j.heliyon.2024.e37481.

The Anti-Diabetic Effects of Medicinal Plants Belonging to the Liliaceae Family: Potential Alpha Glucosidase Inhibitors.

Ramadaini T, Sumiwi S, Febrina E Drug Des Devel Ther. 2024; 18:3595-3616.

PMID: 39156483 PMC: 11330250. DOI: 10.2147/DDDT.S464100.

Bibliometric analysis of research on the utilization of nanotechnology in diabetes mellitus and its complications.

Zhang J, He M, Gao G, Sun T Nanomedicine (Lond). 2024; 19(16):1449-1469.

PMID: 39121376 PMC: 11318711. DOI: 10.1080/17435889.2024.2358741.

References

Gu Z, Aimetti A, Wang Q, Dang T, Zhang Y, Veiseh O . Injectable nano-network for glucose-mediated insulin delivery. ACS Nano. 2013; 7(5):4194-201. PMC: 4107450. DOI: 10.1021/nn400630x. View

McNamara K, Tofail S . Nanosystems: the use of nanoalloys, metallic, bimetallic, and magnetic nanoparticles in biomedical applications. Phys Chem Chem Phys. 2015; 17(42):27981-95. DOI: 10.1039/c5cp00831j. View

Schulman R, Moshier E, Rho L, Casey M, Godbold J, Mechanick J . Association of glycemic control parameters with clinical outcomes in chronic critical illness. Endocr Pract. 2014; 20(9):884-93. DOI: 10.4158/EP13324.OR. View

Ghosh P, Han G, De M, Kim C, Rotello V . Gold nanoparticles in delivery applications. Adv Drug Deliv Rev. 2008; 60(11):1307-1315. DOI: 10.1016/j.addr.2008.03.016. View

Hrkach J, Von Hoff D, Mukkaram Ali M, Andrianova E, Auer J, Campbell T . Preclinical development and clinical translation of a PSMA-targeted docetaxel nanoparticle with a differentiated pharmacological profile. Sci Transl Med. 2012; 4(128):128ra39. DOI: 10.1126/scitranslmed.3003651. View

Andralojc K, Srinivas M, Brom M, Joosten L, de Vries I, Eizirik D . Obstacles on the way to the clinical visualisation of beta cells: looking for the Aeneas of molecular imaging to navigate between Scylla and Charybdis. Diabetologia. 2012; 55(5):1247-57. PMC: 3328679. DOI: 10.1007/s00125-012-2491-7. View

Veiseh O, Gunn J, Zhang M . Design and fabrication of magnetic nanoparticles for targeted drug delivery and imaging. Adv Drug Deliv Rev. 2009; 62(3):284-304. PMC: 2827645. DOI: 10.1016/j.addr.2009.11.002. View

Brown S, Kovatchev B, Raghinaru D, Lum J, Buckingham B, Kudva Y . Six-Month Randomized, Multicenter Trial of Closed-Loop Control in Type 1 Diabetes. N Engl J Med. 2019; 381(18):1707-1717. PMC: 7076915. DOI: 10.1056/NEJMoa1907863. View

Peer D, Karp J, Hong S, Farokhzad O, Margalit R, Langer R . Nanocarriers as an emerging platform for cancer therapy. Nat Nanotechnol. 2008; 2(12):751-60. DOI: 10.1038/nnano.2007.387. View

10.

. 6. Glycemic Targets: . Diabetes Care. 2018; 42(Suppl 1):S61-S70. DOI: 10.2337/dc19-S006. View

11.

Porksen N, Nyholm B, Veldhuis J, Butler P, Schmitz O . In humans at least 75% of insulin secretion arises from punctuated insulin secretory bursts. Am J Physiol. 1997; 273(5):E908-14. DOI: 10.1152/ajpendo.1997.273.5.E908. View

12.

Habener J . A perspective on pancreatic stem/progenitor cells. Pediatr Diabetes. 2004; 5 Suppl 2:29-37. DOI: 10.1111/j.1399-543X.2004.00077.x. View

13.

Mansour R, Soleimanifar F, Abazari M, Torabinejad S, Ardeshirylajimi A, Ghoraeian P . Collagen coated electrospun polyethersulfon nanofibers improved insulin producing cells differentiation potential of human induced pluripotent stem cells. Artif Cells Nanomed Biotechnol. 2018; 46(sup3):S734-S739. DOI: 10.1080/21691401.2018.1508031. View

14.

Gaglia J, Guimaraes A, Harisinghani M, Turvey S, Jackson R, Benoist C . Noninvasive imaging of pancreatic islet inflammation in type 1A diabetes patients. J Clin Invest. 2010; 121(1):442-5. PMC: 3007157. DOI: 10.1172/JCI44339. View

15.

Du L, Li Z, Yao J, Wen G, Dong C, Li H . Enzyme free glucose sensing by amino-functionalized silicon quantum dot. Spectrochim Acta A Mol Biomol Spectrosc. 2019; 216:303-309. DOI: 10.1016/j.saa.2019.03.071. View

16.

Dabelea D . The accelerating epidemic of childhood diabetes. Lancet. 2009; 373(9680):1999-2000. DOI: 10.1016/S0140-6736(09)60874-6. View

17.

Streisand R, Monaghan M . Young children with type 1 diabetes: challenges, research, and future directions. Curr Diab Rep. 2014; 14(9):520. PMC: 4113115. DOI: 10.1007/s11892-014-0520-2. View

18.

Brownlee M, Cerami A . A glucose-controlled insulin-delivery system: semisynthetic insulin bound to lectin. Science. 1979; 206(4423):1190-1. DOI: 10.1126/science.505005. View

19.

Schmid C, Haug C, Heinemann L, Freckmann G . System accuracy of blood glucose monitoring systems: impact of use by patients and ambient conditions. Diabetes Technol Ther. 2013; 15(10):889-96. DOI: 10.1089/dia.2013.0047. View

20.

. Progression of retinopathy with intensive versus conventional treatment in the Diabetes Control and Complications Trial. Diabetes Control and Complications Trial Research Group. Ophthalmology. 1995; 102(4):647-61. DOI: 10.1016/s0161-6420(95)30973-6. View